Literature DB >> 16015457

Evidence for classically conditioned fatigue responses in patients receiving chemotherapy treatment for breast cancer.

Dana H Bovbjerg1, Guy H Montgomery, George Raptis.   

Abstract

Fatigue is the most common side effect of chemotherapy for cancer. Not yet explored is the possibility that patients may develop conditioned fatigue responses to clinic cues as a result of the repeated pairing of the clinic environment (conditioned stimulus) with infusions of chemotherapy (unconditioned stimulus) that cause fatigue (unconditioned response). As a first critical test of this possibility, breast cancer patients (N = 82) were studied across their first four cycles of chemotherapy. Consistent with conditioning: (1) fatigue levels in the clinic environment significantly increased with repeated pairings of the clinic environment and chemotherapy administration; (2) fatigue responses in the clinic environment prior to the fourth infusion (CR) were predicted by patients' previous experiences of post-infusion fatigue (UR) above and beyond effects of concurrent emotional distress. These results provide the first evidence in the literature that fatigue can be conditioned. Additional research is warranted to determine the clinical importance of this source of fatigue in chemotherapy patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16015457     DOI: 10.1007/s10865-005-4659-9

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  30 in total

1.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

Authors:  C L Cameron; D Cella; J E Herndon; A B Kornblith; E Zuckerman; E Henderson; R B Weiss; M R Cooper; R T Silver; L Leone; G P Canellos; B A Peterson; J C Holland
Journal:  Health Psychol       Date:  2001-01       Impact factor: 4.267

Review 3.  The role of behavioral conditioning in the development of nausea.

Authors:  Sara Matteson; Joseph Roscoe; Jane Hickok; Gary R Morrow
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

Review 4.  Imagery in human classical conditioning.

Authors:  M R Dadds; D H Bovbjerg; W H Redd; T R Cutmore
Journal:  Psychol Bull       Date:  1997-07       Impact factor: 17.737

5.  Longitudinal analysis of the development of anticipatory nausea.

Authors:  M A Andrykowski; W H Redd
Journal:  J Consult Clin Psychol       Date:  1987-02

Review 6.  Measurement of subjective phenomena in primary care research: the Visual Analogue Scale.

Authors:  M D Miller; D G Ferris
Journal:  Fam Pract Res J       Date:  1993-03

7.  Treatment related psychological distress during adjuvant chemotherapy as a conditioned response.

Authors:  M E Sabbioni; D H Bovbjerg; P B Jacobsen; S L Manne; W H Redd
Journal:  Ann Oncol       Date:  1992-05       Impact factor: 32.976

8.  Anticipatory anxiety in women receiving chemotherapy for breast cancer.

Authors:  P B Jacobsen; D H Bovbjerg; W H Redd
Journal:  Health Psychol       Date:  1993-11       Impact factor: 4.267

9.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer.

Authors:  D H Bovbjerg; W H Redd; L A Maier; J C Holland; L M Lesko; D Niedzwiecki; S C Rubin; T B Hakes
Journal:  J Consult Clin Psychol       Date:  1990-04
View more
  1 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.